Lyme Disease Racial Disparities: Why Diagnoses Are Missed
Lyme disease is often missed in non-White patients—leading to delayed diagnosis, more severe illness, and worse outcomes.
Lyme disease racial disparities affect how quickly patients are diagnosed, how severe their illness becomes, and how they move through the healthcare system.
A large study analyzing more than 168,000 Lyme disease cases found that non-White patients consistently present later and with more advanced disease.
These findings highlight gaps in recognition, diagnosis, and treatment that extend across the entire course of care.
Quick Answer: What Are Lyme Disease Racial Disparities?
Lyme disease racial disparities refer to differences in diagnosis timing, disease severity, and outcomes between racial groups—often resulting in delayed care and more advanced illness in non-White patients.
These disparities are driven by differences in symptom recognition, access to care, and clinical decision-making.
Lyme Disease Racial Disparities by the Numbers
Researchers examined Medicare and Medicaid data across 16 high-incidence states. The findings were striking:
- Non-White children were 77% more likely to develop disseminated disease
- Black children had 96% higher hospitalization rates
- 43% of Black Medicare patients under 65 presented with advanced illness
- Non-White patients were more often diagnosed outside peak tick season
These patterns suggest delays in recognition and diagnosis rather than differences in exposure alone.
Rash Recognition and Missed Diagnoses
The erythema migrans rash is a key early sign of Lyme disease. However, it can be more difficult to recognize on darker skin tones.
When the rash is missed, patients are more likely to progress to neurologic, cardiac, or joint complications.
This is one of the most visible drivers of delayed diagnosis and contributes directly to more severe disease.
For a broader overview of symptom variability, see Lyme disease symptoms guide.
A Broken Diagnostic Journey
Non-White patients often follow a different diagnostic path:
- More emergency department visits instead of primary care
- Multiple visits before diagnosis
- Higher rates of diagnostic testing
- Different antibiotic prescribing patterns
This reflects greater uncertainty in diagnosis and delayed clinical recognition.
This pattern overlaps with what is seen in delayed Lyme disease diagnosis.
Systemic Drivers of Lyme Disease Racial Disparities
These disparities are not caused by a single factor. Several systemic issues contribute:
- Provider education gaps in recognizing Lyme disease across skin tones
- Differences in quality of care despite similar insurance coverage
- Seasonal bias affecting clinical suspicion
These factors can delay treatment even when patients present with symptoms.
The Consequences of Delayed Diagnosis
Delayed diagnosis increases the risk of more severe illness, including neurologic, cardiac, and joint involvement.
It also increases the likelihood of post-treatment Lyme disease syndrome (PTLDS), where symptoms persist despite treatment.
For many patients, a missed early diagnosis can lead to months or years of ongoing symptoms.
Why This Matters Clinically
Lyme disease is often treatable when identified early.
When diagnosis is delayed, treatment becomes more complex, recovery may be slower, and outcomes may be less predictable.
This is where improving recognition can have the greatest impact.
Addressing Lyme Disease Racial Disparities
Reducing disparities requires changes at multiple levels:
- Improved clinician education on diverse presentations
- Better recognition of symptoms across skin tones
- Earlier evaluation in endemic areas
- System-level efforts to reduce diagnostic delays
These changes can improve outcomes by shifting diagnosis earlier in the disease course.
Clinical Perspective
Lyme disease should be considered in any patient with compatible symptoms, regardless of race or season.
Delayed recognition often reflects how symptoms are interpreted—not how the disease behaves.
Improving outcomes begins with recognizing patterns that might otherwise be overlooked.
Clinical Takeaway
Lyme disease racial disparities are not just statistical—they directly affect patient outcomes.
Earlier recognition across all patient populations can reduce complications and improve recovery.
Related Reading
- Delayed Lyme disease diagnosis
- Lyme disease symptoms guide
- Post-treatment Lyme disease syndrome (PTLDS)
- Misdiagnosing Lyme disease
References:
- Gould LH, Willis SJ, Prener CG, et al. Differences in Lyme Disease Diagnosis among Medicaid and Medicare Beneficiaries, United States, 2016–2021. Emerg Infect Dis. 2025;31(9).
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
This is so important! I have thought about this for years, as an engorged tick can look like a benign skin tag on darker skin.
Knowing from experience how poor diagnosis is for white people makes this all the more horrific! 🙁